abstract |
For example, provided herein are 5,5-condensed heteroarylene hepatitis C virus inhibitor compounds of formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and methods for their preparation. Also provided are methods of their use for the treatment in hosts in need of treatment for HCV infection. Formula (I), (IA), (IB). [Chemical 1] [Selection figure] None |